Search results for: 'Preferred Destination for Clinical Trials 2020'

Tamil Nadu is the second-largest contributor to India’s GDP and is a leading economic powerhouse. Favourable industrial policies, suitable infrastructure for industrial growth, a large talent pool, and a high rate of urbanisation have contributed to industrial growth and output over the last 20 years. The state is a leading destination for the au...

06 Oct 2022  |  North America  |  Market Research

Clinical Decision Support Solutions for the Intensive Care Unit, United States, 2022

Transformative Mega Trends Create New Growth Opportunities

Infographics

×

Key Issues Addressed

This research study examines the intensive care unit (ICU) clinical decision support solutions (CDSS) industry in the United States, analyzing the emerging trends that are influencing this space. Hospitals aggregate a large amount of continually changing patient data from disparate sources. Asynchronously reported data elements with different ou...

Healthcare systems today are facing a convergence of pressures that threaten both operational stability and patient outcomes. Workforce shortages, clinician burnout, rising costs, and persistent health inequities are compounded by the growing demands of an aging population with complex needs.These challenges are not isolated—they interact and inten...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

COVID-19 has brought about major changes for companies and industries globally. Numerous employees work remotely, companies increasingly pursue digital transformation initiatives, and more applications are being moved to the cloud. Within this context, what role does security play for IT decision makers This study analyzes two major Frost & Sulliva...

The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

The mHealth enabled care market is growing at a rapid pace with over 0.15 million health apps in 2015 leading to an endless number of possibilities of smartphone usage for revolutionizing healthcare. From reading and analyzing a patient’s vital body data, medication adherence, and chronic disease management to early diagnosis of complex disorders w...